BRIEF published on 04/15/2026 at 17:50, 6 months 23 days ago MACOMPTA.FR Reports 28.1% Increase in Q3 Sales for Fiscal Year 25/26 Software Solutions Macompta.fr Q3 Sales Fiscal Year 25/26 28.1% Growth
BRIEF published on 04/15/2026 at 17:50, 6 months 23 days ago MACOMPTA.FR Enregistre une Croissance de 28,1 % au T3 25/26 Chiffre D'affaires Croissance Logiciels Macompta.fr Experts-comptables
BRIEF published on 04/15/2026 at 17:50, 6 months 23 days ago MACOMPTA.FR Records Growth of 28.1% in Q3 25/26 Revenue Growth Software Macompta.fr Chartered Accountants
BRIEF published on 04/15/2026 at 17:50, 6 months 23 days ago MACOMPTA.FR annonce une hausse de 28,1 % de son chiffre d'affaires au troisième trimestre de l'exercice 2025/26. Solutions Logicielles Macompta.fr Ventes Du Troisième Trimestre Exercice 25/26 Croissance De 28,1 %
PRESS RELEASE published on 04/15/2026 at 17:45, 6 months 23 days ago MACOMPTA.FR : Chiffre d'affaires T3 25/26 : + 28,1 % MACOMPTA.FR publie une forte croissance de son chiffre d'affaires au T3 25/26, en hausse de 28,1%. L'éditeur français de solutions logicielles confirme son succès Chiffre D'affaires Croissance Solutions Logicielles Macompta.fr Expert-comptable
PRESS RELEASE published on 04/15/2026 at 17:45, 6 months 23 days ago MACOMPTA.FR: Q3 Sales 25/26: +28.1% MACOMPTA.FR reports a strong 28.1% increase in Q3 sales for fiscal year 25/26. The French software company offers business solutions & accounting tools for over 100,000 users Macompta.fr Q3 Sales French Software Company 28.1% Accounting Tools
BRIEF published on 03/30/2026 at 08:50, 7 months 9 days ago MACOMPTA.FR s'associe avec CIC CIB pour un contrat de liquidité Contrat De Liquidité AMF Euronext Growth Macompta.fr CIC CIB
BRIEF published on 03/30/2026 at 08:50, 7 months 9 days ago MACOMPTA.FR Enters Liquidity Agreement with CIC CIB Liquidity Agreement Euronext Growth AMF Regulations Macompta.fr CIC CIB
BRIEF published on 03/30/2026 at 08:50, 7 months 9 days ago MACOMPTA.FR partners with CIC CIB for a liquidity contract Liquidity Contract AMF Euronext Growth Macompta.fr CIC CIB
BRIEF published on 03/30/2026 at 08:50, 7 months 9 days ago MACOMPTA.FR conclut un accord de liquidité avec CIC CIB Euronext Croissance Macompta.fr Accord De Liquidité Règlementation De L'AMF CIC CIB
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:00, 16 minutes ago Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market
Published on 11/09/2026 at 07:00, 16 minutes ago Cicor receives awards for two major defence programmes
Published on 11/09/2026 at 01:55, 5 hours 21 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 19 hours 6 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 21 hours 1 minute ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/09/2026 at 07:00, 17 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 17 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 17 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 17 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
